X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cmt1a (166) 166
humans (153) 153
charcot-marie-tooth disease - genetics (94) 94
female (83) 83
male (81) 81
clinical neurology (76) 76
neurosciences (76) 76
index medicus (69) 69
charcot-marie-tooth disease (64) 64
myelin proteins - genetics (62) 62
adult (58) 58
duplication (57) 57
hereditary neuropathy (56) 56
genetics & heredity (54) 54
middle aged (49) 49
pmp22 (42) 42
pressure palsies (40) 40
charcot-marie-tooth disease - diagnosis (39) 39
neuropathy (39) 39
charcot-marie-tooth disease - pathology (38) 38
phenotype (36) 36
adolescent (35) 35
charcot-marie-tooth disease - physiopathology (33) 33
chromosomes, human, pair 17 (32) 32
marie-tooth-disease (32) 32
animals (29) 29
gene duplication (29) 29
hereditary motor (29) 29
liability (29) 29
gene dosage (28) 28
hnpp (28) 28
charcot-marie-tooth (27) 27
child (27) 27
gene (27) 27
pedigree (27) 27
diagnosis (23) 23
point mutation (23) 23
aged (22) 22
cmt1a duplication (21) 21
disease type 1a (21) 21
hereditary sensory and motor neuropathy - genetics (21) 21
mutation (21) 21
pmp22 gene (20) 20
schwann-cells (20) 20
congenital, hereditary, and neonatal diseases and abnormalities (18) 18
disease models, animal (18) 18
expression (18) 18
myelin (18) 18
polymerase chain reaction (18) 18
analysis (17) 17
gene deletion (17) 17
genetics (17) 17
hereditary neuropathy with liability to pressure palsies (17) 17
mechanism (17) 17
neurology (17) 17
child, preschool (16) 16
mice (16) 16
charcot-marie-tooth disease - metabolism (15) 15
disease (15) 15
pmp-22 (15) 15
sensory neuropathy (15) 15
tooth disease type-1a (15) 15
ascorbic-acid treatment (14) 14
base sequence (14) 14
chromosomes, human, pair 17 - genetics (14) 14
electrophysiology (14) 14
myelin proteins - metabolism (14) 14
young adult (14) 14
biochemistry & molecular biology (13) 13
chromosome mapping (13) 13
deletion (13) 13
dna mutational analysis (13) 13
genetic aspects (13) 13
medicine, research & experimental (13) 13
molecular sequence data (13) 13
mutations (13) 13
recombination (13) 13
research (13) 13
17p11.2 duplication (12) 12
chromosome-17 (12) 12
linkage (12) 12
peripheral neuropathy (12) 12
schwann cells - metabolism (12) 12
charcot-marie-tooth disease - complications (11) 11
chromosome 17 (11) 11
deletions (11) 11
medicine (11) 11
neural conduction - physiology (11) 11
peripheral myelin protein-22 (11) 11
polymerase chain reaction - methods (11) 11
polyneuropathy (11) 11
sequences (11) 11
article (10) 10
charcot-marie-tooth disease - drug therapy (10) 10
cmt (10) 10
demyelination (10) 10
dna (10) 10
features (10) 10
in situ hybridization, fluorescence (10) 10
motor (10) 10
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (211) 211
French (4) 4
Chinese (2) 2
Spanish (2) 2
Czech (1) 1
German (1) 1
Italian (1) 1
Japanese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Neurophysiology, ISSN 1388-2457, 09/2017, Volume 128, Issue 9, pp. e195 - e195
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.clinph.2017.07.060 
Multi-unit EMG | Restless legs syndrome | Axonal excitability | CMT1A
Journal Article
Journal of the Peripheral Nervous System, ISSN 1085-9489, 12/2008, Volume 13, Issue 4, pp. 299 - 304
Journal Article
F1000Research, ISSN 2046-1402, 02/2015, Volume 4, p. 53
This brief review of current research progress on Charcot-Marie-Tooth (CMT) disease is a summary of discussions initiated at the Hereditary Neuropathy... 
Molecular Pharmacology | Neuropharmacology & Psychopharmacology | Musculoskeletal Pharmacology | Bioinformatics | Genomics
Journal Article
European Journal of Neurology, ISSN 1351-5101, 10/2016, Volume 23, Issue 10, pp. 1566 - 1571
Journal Article
Journal Article
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 2014, Volume 9, Issue 1, pp. 201 - 201
Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited sensory and motor peripheral neuropathy. It is caused by PMP22 overexpression which... 
Sorbitol | Repurposing | Low dose | Baclofen | Synergy | Combination therapy | Naltrexone | Systems Biology | CMT1A | PATHWAYS | MEDICINE, RESEARCH & EXPERIMENTAL | MARIE-TOOTH-DISEASE | PROTEIN | INJURY | DORSAL-ROOT GANGLIA | SPINAL-CORD | CANCER | 1A | IN-VITRO | TRANSGENIC RAT MODEL | GENETICS & HEREDITY | Coculture Techniques | Male | Nerve Fibers, Myelinated - pathology | Sorbitol - administration & dosage | Female | Drug Therapy, Combination | Sciatic Neuropathy - drug therapy | Charcot-Marie-Tooth Disease - metabolism | Naltrexone - administration & dosage | Disease Models, Animal | Nerve Fibers, Myelinated - metabolism | Rats, Transgenic | Baclofen - administration & dosage | Myelin Proteins - antagonists & inhibitors | Nerve Fibers, Myelinated - drug effects | Gene Expression Regulation | Myelin Proteins - biosynthesis | Axons - drug effects | Axons - metabolism | Rats | Sciatic Neuropathy - pathology | Charcot-Marie-Tooth Disease - drug therapy | Charcot-Marie-Tooth Disease - pathology | Down-Regulation - drug effects | Rats, Sprague-Dawley | Down-Regulation - physiology | Animals | Axons - pathology | Drug Repositioning - methods | Mice | Sciatic Neuropathy - metabolism | Care and treatment | Charcot-Marie-Tooth disease | Patient outcomes | Genetic aspects | Drug therapy, Combination | Health aspects | Risk factors | Drug approval | Analysis | Drugs | Proteins | Studies | Disease | Rodents | Gene expression | Experiments | Bioinformatics | Index Medicus
Journal Article
Acta Neurobiologiae Experimentalis, ISSN 0065-1400, 2018, Volume 78, Issue 3, pp. 198 - 209
Charcot-Marie-Tooth type 1A (CMT1A) is a dysmyelinating disease of the peripheral nervous system that results in a slow progressive weakening and wasting of... 
Adenylyl cyclase activity | Drug therapies | GPCRs | CMT1A | CAMP signaling pathway | Gene dosage effect of PMP22 | drug therapies | cAMP signaling pathway | gene dosage effect of PMP22 | NEUROSCIENCES | adenylyl cyclase activity | PERIPHERAL MYELIN PROTEIN-22 | TRANSGENIC RAT MODEL | PMP22 GENE | ASCORBIC-ACID TREATMENT | NEUROACTIVE STEROIDS | HEREDITARY NEUROPATHY | SCHWANN-CELLS | PRESSURE PALSIES | MEMBRANE PROGESTIN RECEPTOR | CMT1A NEUROPATHY | Animals | Receptors, Muscarinic - drug effects | Receptors, G-Protein-Coupled - metabolism | Humans | Adenylyl Cyclases - metabolism | Charcot-Marie-Tooth Disease - drug therapy | Myelin Proteins - metabolism | Receptors, G-Protein-Coupled - drug effects | Charcot-Marie-Tooth Disease - metabolism | Hereditary Sensory and Motor Neuropathy - drug therapy | Sorbitol | Cell proliferation | Ascorbic acid | Acetylcholine receptors (muscarinic) | Pathogenesis | Medical services | Clinical trials | Opioid receptors (type mu) | Nervous system | Neuropathy | Naltrexone | Neuromodulation | Modulators | Proteins | Receptors | Metabotropic receptors | Charcot-Marie-Tooth disease | Baclofen | Peripheral myelin protein 22 | Peripheral nervous system | γ-Aminobutyric acid B receptors | Medical research | Neurons | Myelin | Schwann cells | Muscles | Pharmacology | Gene expression | Onapristone | Acids | Progesterone | Synergistic effect
Journal Article
Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, ISSN 0736-0258, 11/2017, Volume 34, Issue 6, pp. 508 - 511
Journal Article
Neuromuscular Disorders, ISSN 0960-8966, 06/2018, Volume 28, Issue 6, pp. 502 - 507
Charcot–Marie–Tooth disease type 1A (CMT1A) is caused by 1.5-fold increased dosage of the ; however, onset age and severity vary considerably among patients.... 
Association study | Genetic modifier | miR-149 | CMT1A | Phenotypic heterogeneity | POPULATION | APOPTOSIS | CELLS | PHENOTYPE | MODEL | NEUROSCIENCES | CLINICAL NEUROLOGY | NEUROPATHY | TARGETS | DUPLICATION | MICRORNA | RESOURCE | Gene expression | Genetic aspects | Single nucleotide polymorphisms
Journal Article